[140 Pages Report] The 3D cell culture market is expected to reach USD 1,720.3 Million by 2022 from USD 570.4 Million in 2016 growing at a CAGR of 20.3% during the forecast period. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022.

The objectives of this study are as follows:

To define, describe, segment, and forecast the global market on the basis of product application, end user, and region

To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, challenges, and market-specific trends)

To analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market

To analyze the opportunities in the market for stakeholders and provide details of competitive landscape for market leaders

To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)

To profile key players and comprehensively analyze their market shares and core competencies

To track and analyze competitive developments such as agreements, partnerships, and collaborations; acquisitions; product launches and approvals; expansions; and R&D activities in the global market

Research Methodology

The study estimates the 3D cell culture market size for 2017 and projects its demand till 2022. In the primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information for the report. Primary sources from the demand side include various industry CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from the various players in the global market. For the market estimation process, both top-down and bottom-up approaches were used to estimate and validate the market size of the 3D cell culture market as well as to estimate the market size of various other dependent submarkets. All possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data was consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report.

The global 3D cell culture market is projected to reach USD 1,720.3 Million by 2022 from USD 682.8 Million in 2017, at a CAGR of 20.3%. Factors such as rising focus on developing alternative methods for animal testing, funding initiatives from government and private investors, technological advancements and product launches, and growing awareness are driving the growth of the market.

The report segments the global market into by type of product, application, end user, and region.

Based on product, the market is segmented into scaffold-based 3D cell culture, scaffold-free 3D cell culture, microfluidics-based 3D cell culture, and magnetic levitation and 3D bioprinting. The scaffold-based 3D cell culture products segment is expected to account for the largest market share in 2017, and is projected to register the highest CAGR during the forecast period. The high growth in this segment is attributed to the ability of scaffold-based products to mimic in vivo conditions, thus driving their adoption among end users.

By type, the scaffold-based 3D cell culture market is segmented into hydrogels/ECM analogs, solid scaffolds, and micropatterned surfaces. The hydrogels/ECM segment analogs are expected to account for the largest share of the scaffold-based market owing to their wide acceptance among researchers.

The global market, by applications, is segmented into cancer and stem cell research, drug discovery and toxicology testing, and tissue engineering & regenerative medicine. The cancer and stem cell research segment is estimated to account for the largest market share in 2017. Growth of this application segment is attributed to increasing incidence of cancer and significant funding initiatives for cancer research from government as well as private organizations.

Based on end users, the market is segmented into pharmaceutical & biotechnology companies and research institutes. In 2017, pharmaceutical and biotechnology companies are expected to form the largest end-user segment. The presence of a large number of pharmaceutical and biotechnology companies, increasing R&D spending in these companies, and growing focus on alternative testing models instead of animal techniques are the key drivers for this end-user segment.

The market is dominated by North America, followed by Europe, Asia Pacific, and the Rest of the World (RoW). The dominance of the North American market is attributed to factors such as increase in incidence of cancer, presence of well-established pharmaceutical and biotechnology industry, and availability of technologically advanced products.

While the laboratory informatics market represents significant growth opportunities, market growth may be hindered due to lack of infrastructure for 3D cell culture research. The market is highly competitive with the presence of several big and small players.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst